Imaging and response criteria in gliomas

Area of Science:

• Neuroimaging
• Oncology
• Radiology

Background:

• Brain tumor imaging has evolved from anatomical assessment to probing tumor biology and treatment response.
• Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) are key modalities in this advancement.
• High-grade gliomas require sophisticated imaging for accurate diagnosis and management.

Purpose of the Study:

• To review recent advancements in the imaging of gliomas, with a specific focus on high-grade gliomas.
• To discuss the integration of novel imaging techniques into clinical trials and practice.
• To outline the potential uses and limitations of current and emerging imaging technologies.

Main Methods:

• Review of recent literature on advanced MRI and PET techniques for glioma imaging.
• Discussion of updated response assessment criteria for high-grade gliomas.
• Exploration of emerging imaging modalities like perfusion, diffusion, and PET tracers.

Main Results:

• Updated response assessment criteria for high-grade gliomas were published in 2010, standardizing clinical trial evaluations.
• Advanced MRI and PET techniques offer insights into tumor biology and treatment efficacy.
• Promising future techniques include vascular permeability measurement, perfusion imaging, diffusion imaging, and novel PET tracers.

Conclusions:

• Neuroimaging advances allow noninvasive visualization of tumor response to therapy over time.
• Validated advanced imaging tools will significantly enhance the understanding of glioma biology.
• These techniques are crucial for improving glioma patient management and therapeutic strategies.